Assessment of safety and efficacy of ferric carboxymaltose (Ferinject ®) in the management of iron deficiency with anaemia (IDA) or without anaemia in children and adolescents with inflammatory bowel disease (IBD)

被引：0
|
作者：
Hachemi, S. [1 ]
Mutalib, M. [1 ]
Chadokufa, S. [1 ]
Huggett, B. [1 ]
Sider, S. [1 ]
Shah, N. [1 ]
Whitley, L. [2 ]
McCartney, S. [2 ]
Kiparissi, F. [1 ,2 ]
机构：
[1] Great Ormond St Hosp Sick Children, Paediat Gastroenterol, London WC1N 3JH, England
[2] Univ Coll London Hosp NHS Fdn Trust, Dept Gastroenterol, London, England
来源：
JOURNAL OF CROHNS & COLITIS | 2015年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P377
引用
收藏
页码：S267 / S267
页数：1
相关论文
共 50 条
  • [31] An audit comparing a new intravenous (IV) iron preparation, ferric carboxymaltose (Ferinject) to IV iron dextran (Cosmofer) for the treatment of iron-deficiency anaemia in pregnancy
    Myers, B.
    Myers, O. J.
    Moore, J.
    BRITISH JOURNAL OF HAEMATOLOGY, 2011, 153 : 30 - 30
  • [32] Efficacy of a micronised, dispersible ferric pyrophosphate in children with anaemia associated with inflammatory bowel disease.
    Wegner, A.
    Mierzwa, G.
    Wiecek, S.
    Korlatowicz-Bilar, A.
    Dadalski, M.
    Korczowski, B.
    Kierkus, J.
    JOURNAL OF CROHNS & COLITIS, 2016, 10 : S286 - S287
  • [33] Real-world experience: Treatment of iron deficiency anaemia (IDA) with intravenous (IV) iron in inflammatory bowel disease
    Kearns, J.
    Jacob, S.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S560 - S560
  • [34] Efficacy and cost effectiveness of intravenous ferric carboxymaltose versus iron sucrose in adult patients with iron deficiency anaemia
    Basha, Ahmad
    Ibrahim, Mohamed Izham Mohamed
    Hamad, Anas
    Chandra, Prem
    Omar, Nabil E.
    Abdullah, Mohamed Abdul Jaber
    Aldapt, Mahmood B.
    Hussein, Radwa M.
    Mahfouz, Ahmed
    Adel, Ahmad A.
    Shwaylia, Hawraa M.
    Ekeibed, Yaslem
    AbuMousa, Rami
    Yassin, Mohamed A.
    PLOS ONE, 2021, 16 (08):
  • [35] Poor recognition and management of iron deficiency anaemia in inflammatory bowel disease: a missed opportunity
    Subramaniam, S.
    Besherdas, K.
    JOURNAL OF CROHNS & COLITIS, 2015, 9 : S305 - S305
  • [36] COST-EFFECTIVENESS OF FERRIC CARBOXYMALTOSE (FCM) IN THE TREATMENT OF IRON DEFICIENCY ANEMIA IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE (IBD)
    Walter, E.
    Lazic-Peric, A.
    Schalle, K.
    VALUE IN HEALTH, 2017, 20 (09) : A634 - A635
  • [37] COST-EFFECTIVENESS ANALYSIS OF FERRIC MALTOL VERSUS FERRIC CARBOXYMALTOSE FOR THE TREATMENT OF IRON DEFICIENCY ANAEMIA IN IBD PATIENTS IN SWEDEN AND FINLAND
    Hjelmgren, J.
    Ericson, O.
    Niska, P.
    Kukkonen, P.
    Birgegard, G.
    VALUE IN HEALTH, 2018, 21 : S452 - S453
  • [38] Retrospective review of effectiveness and safety of intravenous ferric carboxymaltose given to children with iron deficiency anaemia in one UK tertiary centre
    Michelle Li Nien Tan
    Paul-Michael Windscheif
    Graham Thornton
    Ed Gaynor
    Astor Rodrigues
    Lucy Howarth
    European Journal of Pediatrics, 2017, 176 : 1419 - 1423
  • [39] Comparative Study of Efficacy and Safety of Ferric Carboxymaltose Versus Iron Sucrose in Post-partum Anaemia
    Sharma N.
    Thiek J.L.
    Natung T.
    Ahanthem S.S.
    The Journal of Obstetrics and Gynecology of India, 2017, 67 (4) : 253 - 257
  • [40] IV iron treatment of iron deficiency anaemia with ferumoxytol in patients with inflammatory bowel disease unable to take oral iron: A randomised controlled trial vs. ferric carboxymaltose
    Strauss, W.
    Dahl, N.
    Jiang, J.
    Bernard, K.
    Kaper, R.
    Krop, J.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S416 - S417
12345